← Open Payments lookup

RANDALL SATO: Open Payments

NPI 1619604022 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$394 in 9 payments from 5 companies in 2025. Trend: 2023 $96 · 2024 $306 · 2025 $394

Food & beverage: $394
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.4$151
Neurocrine BioSciences, Inc.1$128
Teva Pharmaceuticals USA, Inc.2$52
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$38
Janssen Pharmaceuticals, Inc1$25

Products named: ABILIFY ASIMTUFII, INGREZZA, AUSTEDO XR, CAPLYTA, INVEGA SUSTENNA, ABILIFY MAINTENA.

Industry payments across HI — which companies pay providers there.